ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer - Armstrong, A J; Szmulewitz, R Z; Petrylak, D P (J Clin Oncol, 2019)
et al.